Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03500783

Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass (NOinCPB)

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

Conditions Cardiopulmonary Bypass Coronary Artery Bypass Coronary Artery Disease Nitric Oxide Reperfusion Injury, Myocardial

Interventions Nitric Oxide Standard CPB

Updated 6 times since 2018 Last updated: Jul 1, 2019 Started: May 15, 2015 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03500783, this PHASE1/PHASE2 trial focuses on Cardiopulmonary Bypass and Coronary Artery Bypass and remains completed. Sponsored by Tomsk National Research Medical Center of the Russian Academy of Sciences, it has been updated 6 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Aug 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Aug 2019 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

May 2018 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tomsk National Research Medical Center of the Russian Academy of Sciences

Data source: Tomsk National Research Medical Center of the Russian Academy of Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.